TheraRadar
Landscape / Women's Health
Data updated: Jun 28, 2026

Contraception Clinical Trial Landscape

Contraception is being studied across 47 clinical trials registered since 2008, with 12 programs currently active. The competitive pipeline includes 3 active Phase 3 trials, 5 active Phase 2 trials, and 2 active Phase 1 trials.

Top industry sponsors include YourChoice Therapeutics, Inc., Mylan Pharmaceuticals Inc, Next Life Sciences.

Trial activity

12 active / 47 total since 2008
Active by phase 3 Ph3 / 13 5 Ph2 / 14 2 Ph1 / 11 2 Ph4 / 9

Sponsor activity

Who is running trials now — green active, blue completed, red failed/terminated.

Sorted by active Active Done Failed
YourChoice Therapeutics, Inc. 1 1 0
Mylan Pharmaceuticals Inc 1 0 0
Next Life Sciences 1 0 0
Bayer 0 3 0

How the field has grown

New-trial starts peaked in 2025 (6 registered). The right-hand chart shows median Phase 3 enrollment by start year — the number in parentheses is that year's Phase 3 trial count (6 in total), so single-trial years (and years with no Phase 3 starts) are obvious. Both are by trial start date; the current year is partial.

New trials started by year

2016
2
2017
5
2018
4
2019
0
2020
2
2021
3
2022
3
2023
3
2024
1
2025
6
2026
1

TheraRadar.com

Median Phase 3 enrollment by start year

2016 (1)
95
2017 (2)
1,188
2018 (1)
860
2019 (0)
0
2020 (0)
0
2021 (0)
0
2022 (0)
0
2023 (0)
0
2024 (0)
0
2025 (2)
1,123
2026 (0)
0

TheraRadar.com

Full trial pipeline

Every active and completed trial across Phase 1–4, with enrollment analytics. Sortable, filterable, exportable with Pro.

NCT06672016 ACTIVE NOT RECRUITING
Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential
Mylan Pharmaceuticals Inc n=1,630
NCT07449299 NOT YET RECRUITING
Rct Assessing Pregnancy - Piroxicam for Ec With Levonorgestrel
University of Utah n=1,458
NCT06394999 ACTIVE NOT RECRUITING
Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive
Leiden University Medical Center n=615
NCT03124160 COMPLETED
Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard
FHI 360 n=1,105
NCT02275546 COMPLETED
Performance and Safety of Vaginal Ring Applicator in Healthy Females (MK-8342A-063)
Organon and Co n=164
NCT03614494 COMPLETED
Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception
Dr. Hang Wun Raymond Li n=860
NCT03208985 COMPLETED
A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions
HRA Pharma n=1,270
NCT04089852 WITHDRAWN
Nitrous Oxide for Pain Management During IUD Insertion in Nulliparous Adolescent Women
Boston Children's Hospital
NCT02866643 COMPLETED
Labor and Delivery Implant Insertion: A Randomized Controlled Trial
Stanford University n=95
NCT01178125 COMPLETED
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
Teva Branded Pharmaceutical Products R&D, Inc. n=2,858
NCT02078063 COMPLETED
Analgesia for Insertion of Intrauterine Contraception
Karolinska Institutet n=86
NCT00996580 COMPLETED
A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy
Teva Women's Health n=3,597
NCT00777556 COMPLETED
Emergency Contraception Actual Use Study
Duramed Research n=343

Full Contraception Pipeline

Every trial across Phase 1–4, plus enrollment analytics. Sortable, filterable, exportable.

Unlock with Pro

Data: ClinicalTrials.gov · Trials registered 2008 onwards · Industry sponsors only